Assessing late presentation for female adolescents and young women with HIV in 2019, South Africa
| Autor: | Naseem Cassim, Deborah K. Glencross, Lindi-Marie Coetzee |
|---|---|
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | European Journal of Public Health. 30 |
| ISSN: | 1464-360X 1101-1262 |
| Popis: | Background South Africa has the biggest HIV epidemic in the world, with an estimated 7.1million people living with HIV in 2018. In 2016, women aged 15-24 contributed 37% of new infections. Poverty, low status, gender-based violence (GBV) and intergenerational relationships possibly contribute to this disparate HIV prevalence. The objective of this study was to describe very advanced HIV disease (CD4< count Methods Specimen level CD4 laboratory data of female patients aged 15-24 was extracted for the 2019 calendar year. Patients were categorized as adolescents (15-19) or young women (20-24), in age categories of (i) 15-16, (ii) 17-19, (iii) 20-21 and (iv) 22-24 years. Frequency tables were used to report test volumes and the percentage of samples with counts Results Amongst 259 088 CD4 outcomes extracted, 5.4% of samples had counts Conclusions This study demonstrated unacceptable rates of very advanced HIV disease in female adolescents and young women, suggesting HIV seroconversion as teenagers or younger. Evidence-based specific health care interventions for these girls are urgently required, including tailoring social services and health facilities to secure the sexual health of girls and young women. Key messages Very advanced HIV disease presentation in female adolescents is unacceptably high. Young women and adolescents with late presentation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|